Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
FEMY
Valuation N/A
FEMASYS INC
Price$2.05
Model IV—
P/IV—
Market implies +59.3%/yr
FONR
Valuation N/A
FONAR CORP
Price$19.09
Model IV—
P/IV—
Limited data — see page
GCTK
Valuation N/A
Glucotrack, Inc.
Price$1.11
Model IV—
P/IV—
Limited data — see page
GEHC
Deeply overvalued
GE HealthCare Technologies Inc.
Price$64.22
Model IV$47.44
P/IV1.31
Premium +35%
Return to IV: -26.1%
Market implies +9.1%/yr
vs model +5.9% · above model
GKOS
Valuation N/A
GLAUKOS Corp
Price$161.29
Model IV—
P/IV—
Market implies +25.5%/yr
GMED
Deeply undervalued
GLOBUS MEDICAL INC
Price$73.33
Model IV$183.41
P/IV0.45
Discount 60%
Return to IV: +150.1%
Market implies +6.4%/yr
vs model +25.0% · below model
GUTS
Valuation N/A
FRACTYL HEALTH, INC.
Price$4.23
Model IV—
P/IV—
Market implies +140.7%/yr
vs model +15.0% · above model
HAE
Deeply undervalued
HAEMONETICS CORP
Price$119.47
Model IV$171.50
P/IV0.40
Discount 30%
Return to IV: +43.6%
Market implies +3.7%/yr
vs model +10.4% · below model
HTFL
Deeply overvalued
Heartflow, Inc.
Price$47.63
Model IV$12.14
P/IV1.45
Premium +292%
Return to IV: -74.5%
Market implies +23.3%/yr
vs model +42.1% · below model
HYPR
Deeply overvalued
Hyperfine, Inc.
Price$0.94
Model IV$0.42
P/IV3.75
Premium +126%
Return to IV: -55.7%
Market implies +16.8%/yr
vs model +50.0% · below model
IART
Fairly valued
INTEGRA LIFESCIENCES HOLDINGS CORP
Price$13.41
Model IV$13.17
P/IV1.22
Premium +2%
Return to IV: -1.8%
Market implies +3.9%/yr
vs model +2.0% · in line
ICCM
Valuation N/A
IceCure Medical Ltd.
Price$1.13
Model IV—
P/IV—
Market implies +79.3%/yr
vs model +2.0% · above model
ICU
Valuation N/A
SeaStar Medical Holding Corp
Price$3.49
Model IV—
P/IV—
Market implies +15.5%/yr
vs model +15.0% · in line
ICUCW
Valuation N/A
SeaStar Medical Holding Corp
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +15.0% · below model
ICUI
Deeply overvalued
ICU MEDICAL INC/DE
Price$157.18
Model IV$50.94
P/IV2.66
Premium +209%
Return to IV: -67.6%
Market implies +25.5%/yr
vs model +12.9% · above model
INBS
Deeply overvalued
INTELLIGENT BIO SOLUTIONS INC.
Price$1.57
Model IV$0.66
P/IV3.89
Premium +138%
Return to IV: -58.0%
Market implies +4.9%/yr
vs model +11.4% · below model
INFU
Deeply overvalued
InfuSystem Holdings, Inc
Price$13.41
Model IV$10.28
P/IV0.88
Premium +30%
Return to IV: -23.4%
Market implies +10.0%/yr
vs model +10.3% · in line
INGN
Deeply undervalued
Inogen Inc
Price$5.94
Model IV$9.60
P/IV0.68
Discount 38%
Return to IV: +61.6%
Market implies -10.9%/yr
vs model +2.0% · below model
INMD
Undervalued
InMode Ltd.
Price$14.08
Model IV$17.75
P/IV0.80
Discount 21%
Return to IV: +26.1%
Market implies +1.8%/yr
vs model +7.3% · below model
INSP
Deeply undervalued
Inspire Medical Systems, Inc.
Price$66.69
Model IV$180.13
P/IV0.23
Discount 63%
Return to IV: +170.1%
Market implies -17.8%/yr
vs model +40.6% · below model
IRIX
Deeply undervalued
IRIDEX CORP
Price$0.90
Model IV$1.72
P/IV0.37
Discount 48%
Return to IV: +91.3%
Market implies -13.3%/yr
vs model +2.0% · below model
IRMD
Deeply overvalued
IRADIMED CORP
Price$85.88
Model IV$37.26
P/IV2.43
Premium +131%
Return to IV: -56.6%
Market implies +22.6%/yr
vs model +16.3% · above model
IRTC
Fairly valued
iRhythm Holdings, Inc.
Price$102.60
Model IV$106.15
P/IV1.07
Discount 3%
Return to IV: +3.5%
Market implies -5.7%/yr
vs model +23.3% · below model
ISRG
Deeply overvalued
INTUITIVE SURGICAL INC
Price$415.41
Model IV$125.77
P/IV3.30
Premium +230%
Return to IV: -69.7%
Market implies +25.0%/yr
vs model +11.6% · above model
ITGR
Deeply overvalued
Integer Holdings Corp
Price$126.65
Model IV$66.32
P/IV1.35
Premium +91%
Return to IV: -47.6%
Market implies +16.8%/yr
vs model +10.7% · above model
ITOC
Valuation N/A
iTonic Holdings Ltd
Price$4.02
Model IV—
P/IV—
Market implies +104.2%/yr
vs model +2.0% · above model
IVF
Valuation N/A
INVO Fertility, Inc.
Price$0.74
Model IV—
P/IV—
Market implies -50.0%/yr
KIDS
Deeply undervalued
ORTHOPEDIATRICS CORP
Price$21.76
Model IV$31.96
P/IV0.70
Discount 32%
Return to IV: +46.9%
Market implies -9.8%/yr
vs model +24.6% · below model
KMTS
Deeply overvalued
KESTRA MEDICAL TECHNOLOGIES, LTD.
Price$25.77
Model IV$9.40
P/IV2.26
Premium +174%
Return to IV: -63.5%
Market implies +17.6%/yr
vs model +50.0% · below model
KRMD
Deeply overvalued
KORU Medical Systems, Inc.
Price$3.00
Model IV$2.18
P/IV1.86
Premium +37%
Return to IV: -27.2%
Market implies -2.4%/yr
vs model +15.0% · below model
LAKE
Deeply undervalued
LAKELAND INDUSTRIES INC
Price$10.09
Model IV$34.48
P/IV0.31
Discount 71%
Return to IV: +241.8%
Market implies -24.5%/yr
vs model +15.0% · below model
LFWD
Deeply undervalued
Lifeward Ltd.
Price$6.43
Model IV$41.32
P/IV0.17
Discount 84%
Return to IV: +542.6%
Market implies -39.0%/yr
vs model +38.6% · below model
LIVN
Overvalued
LivaNova PLC
Price$75.91
Model IV$58.49
P/IV1.32
Premium +30%
Return to IV: -22.9%
Market implies +10.9%/yr
vs model +9.3% · in line
LMAT
Fairly valued
LEMAITRE VASCULAR INC
Price$79.64
Model IV$71.01
P/IV1.13
Premium +12%
Return to IV: -10.8%
Market implies +9.1%/yr
vs model +10.8% · in line
LNSR
Deeply undervalued
LENSAR, Inc.
Price$6.45
Model IV$10.20
P/IV0.57
Discount 37%
Return to IV: +58.1%
Market implies -14.4%/yr
vs model +15.0% · below model
LUCD
Deeply overvalued
Lucid Diagnostics Inc.
Price$0.65
Model IV$0.30
P/IV3.46
Premium +119%
Return to IV: -54.2%
Market implies +7.4%/yr
vs model +50.0% · below model
LUCY
Fairly valued
Innovative Eyewear Inc
Price$0.90
Model IV$0.95
P/IV1.10
Discount 5%
Return to IV: +5.4%
Market implies +0.8%/yr
vs model +40.1% · below model
LUNG
Deeply overvalued
Pulmonx Corp
Price$1.81
Model IV$1.11
P/IV1.49
Premium +64%
Return to IV: -39.0%
Market implies +10.0%/yr
vs model +16.9% · below model
MASI
Valuation N/A
MASI
Price$179.95
Model IV—
P/IV—
Limited data — see page
MBAI
Valuation N/A
Check-Cap Ltd
Price$3.01
Model IV—
P/IV—
Limited data — see page
MBOT
Valuation N/A
Microbot Medical Inc.
Price$1.07
Model IV—
P/IV—
Limited data — see page
MDAI
Deeply overvalued
Spectral AI, Inc.
Price$1.64
Model IV$0.74
P/IV2.24
Premium +122%
Return to IV: -54.9%
Market implies +9.0%/yr
vs model +15.0% · below model
MDAIW
Fairly valued
Spectral AI, Inc.
Price$0.52
Model IV$0.51
P/IV0.88
Premium +1%
Return to IV: -1.0%
Market implies -3.1%/yr
vs model +15.0% · below model
MDLN
Undervalued
Medline Inc.
Price$35.74
Model IV$47.28
P/IV0.77
Discount 24%
Return to IV: +32.3%
Market implies +4.7%/yr
vs model +10.4% · below model
MDT
Fairly valued
Medtronic plc
Price$87.75
Model IV$94.99
P/IV0.94
Discount 8%
Return to IV: +8.3%
Market implies +5.5%/yr
vs model +8.1% · in line
MDXG
Deeply undervalued
MIMEDX GROUP, INC.
Price$4.62
Model IV$8.98
P/IV0.53
Discount 49%
Return to IV: +94.5%
Market implies -0.5%/yr
vs model +11.4% · below model
MLSS
Valuation N/A
MILESTONE SCIENTIFIC INC.
Price$0.36
Model IV—
P/IV—
Market implies +25.0%/yr
MMED
Deeply undervalued
MiniMed Group, Inc.
Price$19.80
Model IV$29.70
P/IV0.69
Discount 33%
Return to IV: +50.0%
Market implies -10.9%/yr
vs model +12.1% · below model
MMM
Deeply overvalued
3M CO
Price$163.58
Model IV$65.91
P/IV2.57
Premium +148%
Return to IV: -59.7%
Market implies +16.0%/yr
vs model +4.5% · above model
MMSI
Fairly valued
MERIT MEDICAL SYSTEMS INC
Price$85.25
Model IV$78.73
P/IV1.11
Premium +8%
Return to IV: -7.6%
Market implies +9.0%/yr
vs model +9.7% · in line
MOBI
Valuation N/A
Mobia Medical, Inc.
Price$8.56
Model IV—
P/IV—
Limited data — see page
MODD
Valuation N/A
Modular Medical, Inc.
Price$2.66
Model IV—
P/IV—
Limited data — see page
MSA
Fairly valued
MSA Safety Inc
Price$178.10
Model IV$184.86
P/IV0.99
Discount 4%
Return to IV: +3.8%
Market implies +7.2%/yr
vs model +9.3% · in line
MYO
Deeply overvalued
MYOMO, INC.
Price$1.41
Model IV$0.81
P/IV2.03
Premium +75%
Return to IV: -42.7%
Market implies +6.8%/yr
vs model +15.0% · below model
NDRA
Valuation N/A
ENDRA Life Sciences Inc.
Price$5.93
Model IV—
P/IV—
Limited data — see page
NEPH
Undervalued
NEPHROS INC
Price$3.29
Model IV$3.98
P/IV0.92
Discount 17%
Return to IV: +20.8%
Market implies +5.2%/yr
vs model +14.5% · below model
NMTC
Deeply undervalued
NEUROONE MEDICAL TECHNOLOGIES Corp
Price$1.08
Model IV$1.66
P/IV2.14
Discount 35%
Return to IV: +53.5%
Market implies -13.3%/yr
vs model +50.0% · below model
NNOX
Valuation N/A
Nano-X Imaging Ltd.
Price$0.57
Model IV—
P/IV—
Limited data — see page
NPCE
Deeply overvalued
NeuroPace Inc
Price$12.39
Model IV$4.76
P/IV3.47
Premium +160%
Return to IV: -61.6%
Market implies +12.6%/yr
vs model +22.0% · below model
NRXS
Valuation N/A
Neuraxis, INC
Price$6.77
Model IV—
P/IV—
Market implies +35.3%/yr
vs model +10.0% · above model